Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass

Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects

(2010) Robert E Steinert et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Gut Hypertrophy After Gastric Bypass Is Associated With Increased Glucagon-Like Peptide 2 and Intestinal Crypt Cell Proliferation

(2010) Carel W. le Roux et al.   ANNALS OF SURGERY

PYY3-36 and Oxyntomodulin Can Be Additive in Their Effect on Food Intake in Overweight and Obese Humans

(2010) B. C. T. Field et al.   DIABETES

Effects of Exendin-4 Alone and With Peptide YY3–36 on Food Intake and Body Weight in Diet-Induced Obese Rats

(2010) Roger D. Reidelberger et al.   Obesity

Vagal Sparing Surgical Technique but Not Stoma Size Affects Body Weight Loss in Rodent Model of Gastric Bypass

(2010) Marco Bueter et al.   OBESITY SURGERY

Gastric Bypass Increases Energy Expenditure in Rats

(2009) Marco Bueter et al.   GASTROENTEROLOGY

The mechanisms of weight loss after bariatric surgery

(2009) J A Tadross et al.   INTERNATIONAL JOURNAL OF OBESITY

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

(2009) Arne Astrup et al.   LANCET

Pharmacokinetics and Efficacy of a Biweekly Dosage Formulation of Exenatide in Zucker Diabetic Fatty (ZDF) Rats

(2009) Hyun-Hee Kwak et al.   PHARMACEUTICAL RESEARCH

Metabolic surgery and gut hormones – A review of bariatric entero-humoral modulation

(2009) Hutan Ashrafian et al.   PHYSIOLOGY & BEHAVIOR

Long-term Weight Regain after Gastric Bypass: A 5-year Prospective Study

(2008) Daniéla Oliveira Magro et al.   OBESITY SURGERY

Release of regulatory gut peptides somatostatin, neurotensin and vasoactive intestinal peptide by acid and hyperosmolal solutions in the intestine in conscious rats

(2008) T. Rudholm et al.   REGULATORY PEPTIDES